microglia modulator (Stanford University Scool of Medicine)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemicroglia modulator (Stanford University Scool of Medicine)
Drug Alias Namesk-09104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford University School of Medicine
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A